Published On: Mon, Aug 11th, 2014

Therapix jumps on cannabis pharmaceutical acquisition

Lara Pharm is developing the active ingredient in cannabis to work in an inhaler.

Medical Cannabis_Clones wikipedia

Therapix Biosciences Ltd. (TASE: TRPH) (formerly NasVax) share price jumped 16.85% today to $0.17 on news that it is to acquire medical cannabis developer Lara Pharm Ltd.

In the first stage Therapix invested $800, 000 for 26% of Lara Pharm. The company is now buying a further 49% for $1.5 million.

Lara Pharm is developing a formulation of THC, the active ingredient in cannabis, to work in an inhaler.

Published by Globes [online], Israel business news – – on August 11, 2014


Read more about: , , , , , , , , , ,

Wordpress site Developed by Fixing WordPress Problems